Enzymicals
Business Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Walther-rathenau-straße 49 b, Greifswald...Website
www.enzymicals.comRevenue
<$5 MillionIndustry
About Enzymicals
Is Enzymicals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Enzymicals
Product Launch: Get notified when Enzymicals launches new products
Funding: Get notified immidiatlly once Enzymicals has new funding data
Website visits: Recent activity has been detected on your website
Check out if Enzymicals is spiking on competitors!
Enzymicals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Enzymicals recently announced quarterly report
Check if Enzymicals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Enzymicals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Enzymicals as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Enzymicals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Enzymicals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Enzymicals.
Enzymicals Tech Stack
A closer look at the technologies used by Enzymicals
Enzymicals News & Media
Enzymicals and Syngulon present an update about their non-exclusive license agreement of May 2020 on the use of Syngulon’s antibiotic free technology to produce enzymes.
The R&D phase for the first project has ended successfully with several enzymes developed and the large-scale production has started. (PRWeb April 27, 2022) Read the full story at https://www.prweb.com/releases/2022/4/prweb18635231.htmEnzymicals and Syngulon sign a non-exclusive license agreement on the...
Enzymicals AG, a German enterprise focusing on industrial biocatalysis and Syngulon, a Belgian synthetic biology company developing original genetic technologies using bacteriocins, announce a... (PRWeb May 16, 2020) Read the full story at https://www.prweb.com/releases/enzymicals_and_syngulon_sign_a_non_exclusive_license_agreement_on_the_use_of_syngulons_antibiotic_free_technology_to_produce_enzymes/prweb17123538.htm
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Enzymicals
Enzymicals AG specializes in industrial biocatalysis, offering tailored enzymes, customized chemicals, and individual process solutions to enhance sustainability in production. Their innovative technologies support various market segments by providing cost-efficient enzyme solutions that improve competitiveness. The company is committed to contribu... Read More